Skip to content
Screener

Erasca, Inc. ERAS Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Amgen logo
AmgenAMGN
$12.98B+17.7%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$14.76M-53.0%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Pfizer logo
PfizerPFE
Tango Therapeutics logo
Tango TherapeuticsTNGX

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.39B+1,400%
Enterprise value$6.39B+1,462%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemMarch 31, 2026December 31, 2025
Property and equipment, net12,61213,303
Operating lease assets28,26529,030
Restricted cash408408
Other assets1,4461,453
Total assets$461,234$396,154
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable$2,163$981

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s deferred tax assets and other non-current assets?
Erasca, Inc. (ERAS) reported deferred tax assets and other non-current assets of $1.45M in Q1 2026.
How has Erasca, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Erasca, Inc.'s deferred tax assets and other non-current assets decreased by 44.7% year-over-year, from $2.62M to $1.45M.
What is the long-term trend for Erasca, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Erasca, Inc.'s deferred tax assets and other non-current assets has grown at a 26.4% compound annual growth rate (CAGR), from $451K to $1.45M.

Ask your AI about Erasca, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude